Press release
Immunoglobulin Market Set to Surge to USD 24.9 Billion by 2032 at a 5.1% CAGR
๐๐ฅ๐จ๐๐๐ฅ ๐๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐๐ฎ๐ฅ๐ข๐ง ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ: ๐๐๐ฒ ๐๐ญ๐๐ญ๐ข๐ฌ๐ญ๐ข๐๐ฌ ๐๐ง๐ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐ข๐ง ๐๐๐๐-๐๐๐๐๐๐ฎ๐ฆ๐ฆ๐๐ซ๐ฒ:
โ The global immunoglobulin market size reached USD 15.7 Billion in 2023.
โ The market is expected to reach USD 24.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032.
โ North America leads the market, accounting for the largest immunoglobulin market share.
โ IgG accounts for the majority of the market share in the product segment due to IgG's effectiveness and safety profile.
โ Immunodeficiency disease holds the largest share in the immunoglobulin industry.
โ Intravenous mode of delivery remains a dominant segment in the market owing to the established protocols and healthcare infrastructure for intravenous administration.
โ The rising prevalence of immunodeficiency diseases is a primary driver of the immunoglobulin market.
โ The increasing Awareness and diagnosis of immunodeficiency diseases is reshaping the immunoglobulin market.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐จ๐ซ ๐ ๐ฌ๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ:ย https://www.imarcgroup.com/immunoglobulin-market/requestsample
๐๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐๐ฎ๐ฅ๐ข๐ง ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐ซ๐๐ง๐๐ฌ ๐๐ง๐ ๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ:
โ ๐๐ข๐ฌ๐ข๐ง๐ ๐ฉ๐ซ๐๐ฏ๐๐ฅ๐๐ง๐๐ ๐จ๐ ๐ข๐ฆ๐ฆ๐ฎ๐ง๐จ๐๐๐๐ข๐๐ข๐๐ง๐๐ฒ ๐๐ข๐ฌ๐๐๐ฌ๐๐ฌ:
As the number of individuals diagnosed with primary immunodeficiency diseases and secondary immunodeficiencies is growing, there is a higher demand for immunoglobulin therapies to manage and treat these conditions. Immunoglobulin therapies are critical for patients with immunodeficiencies, as they provide necessary antibodies to help the body fight infections. This creates a consistent demand for immunoglobulin products. Enhanced awareness and advancements in diagnostic techniques have led to earlier detection of immunodeficiency diseases. This results in timely treatment with immunoglobulin therapies, increasing overall market demand. Many patients with immunodeficiency require lifelong immunoglobulin therapy, leading to sustained usage and a stable market demand. This chronic treatment aspect fosters ongoing revenue for manufacturers.
โ ๐๐ ๐ข๐ง๐ ๐๐จ๐ฉ๐ฎ๐ฅ๐๐ญ๐ข๐จ๐ง:
Older adults often have weakened immune systems, making them more susceptible to infections and chronic diseases. This demographic requires more immunoglobulin therapies to help bolster their immune response. As people age, they are more likely to develop chronic conditions, such as diabetes, heart disease, and autoimmune disorders. Immunoglobulin therapies are increasingly used to manage complications associated with these conditions, leading to greater demand. Diseases that commonly affect older populations, like Alzheimer's disease, Parkinson's disease, and various forms of cancer, can benefit from immunoglobulin treatment, creating a need for these therapies. The elderly often require long-term care and management of multiple health issues, leading to a consistent need for immunoglobulin therapies. This ongoing treatment need fosters a stable market for immunoglobulin products.
โ ๐๐ง๐๐ซ๐๐๐ฌ๐ข๐ง๐ ๐๐ฐ๐๐ซ๐๐ง๐๐ฌ๐ฌ ๐๐ง๐ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ข๐ฌ:
Improved awareness among healthcare providers and the public about immunodeficiency diseases has led to earlier diagnosis. Early intervention with immunoglobulin therapies is crucial for effective management, resulting in higher demand. As patients become more informed about their health conditions, they are more likely to seek medical attention. This proactive approach leads to more diagnoses of immunodeficiency disorders, increasing the patient population in need of immunoglobulin treatment. Ongoing education and training programs for healthcare professionals about immunodeficiency diseases and their treatment options have improved diagnostic rates and treatment outcomes. This professional awareness promotes the prescription of immunoglobulin therapies. The development of advanced diagnostic technologies has facilitated the accurate identification of immunodeficiencies. Improved testing methods increase the likelihood of diagnosis, leading to more patients receiving necessary immunoglobulin treatments.
๐๐ฎ๐ฒ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ฉ๐จ๐ซ๐ญ:ย https://www.imarcgroup.com/checkout?id=4505&method=502
๐๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐๐ฎ๐ฅ๐ข๐ง ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง:
๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐ซ๐จ๐๐ฎ๐๐ญ:
โ IgG
โ IgA
โ IgM
โ IgE
โ IgD
IgG represents the largest segment as IgG is the most abundant immunoglobulin in human serum and is widely used for various therapeutic applications.
๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง:
โ Hypogammaglobulinemia
โ Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
โ Immunodeficiency Disease
โ Myasthenia Gravis
โ Others
Immunodeficiency disease accounts for the majority of the market share. Immunodeficiency diseases require ongoing treatment with immunoglobulin therapies, resulting in a substantial demand that accounts for a significant portion of market share.
๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐จ๐๐ ๐จ๐ ๐๐๐ฅ๐ข๐ฏ๐๐ซ๐ฒ:
โ Intravenous Mode of Delivery
โ Subcutaneous Mode of Delivery
Intravenous mode of delivery exhibits a clear dominance in the market due to its rapid administration and higher plasma levels of immunoglobulin, making it the preferred method for many clinicians and patients.
๐๐ซ๐๐๐ค๐ฎ๐ฉ ๐๐ฒ ๐๐๐ ๐ข๐จ๐ง:
โ North America (United States, Canada)
โ Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
โ Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
โ Latin America (Brazil, Mexico, Others)
โ Middle East and Africa
North America enjoys the leading position in the immunoglobulin market on account of its well-established healthcare infrastructure, higher prevalence of immunodeficiency diseases, and greater access to advanced treatment options.
๐๐จ๐ฉ ๐๐ฆ๐ฆ๐ฎ๐ง๐จ๐ ๐ฅ๐จ๐๐ฎ๐ฅ๐ข๐ง ๐๐๐ซ๐ค๐๐ญ ๐๐๐๐๐๐ซ๐ฌ:
The immunoglobulin market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:
โ ADMA Biologics Inc.
โ Baxter international Inc.
โ Biotest AG
โ CSL Limited
โ Grifols S.A
โ Kedrion S.p.A
โ LFB SA
โ Octapharma AG
โ Sanquin Plasma Products B.V.
โ Takeda Pharmaceutical Company Limited
๐๐ญ๐ก๐๐ซ ๐๐๐ฅ๐๐ญ๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ฒ ๐๐๐๐๐ ๐๐ซ๐จ๐ฎ๐ฉ
๐๐ข๐ซ ๐๐๐๐๐ง๐ฌ๐ ๐๐ฒ๐ฌ๐ญ๐๐ฆ๐ฌ ๐๐๐ซ๐ค๐๐ญ:ย https://www.imarcgroup.com/air-defense-systems-market
๐๐จ๐ฆ๐๐ข๐ง๐ ๐๐๐ซ๐ฏ๐๐ฌ๐ญ๐๐ซ๐ฌ ๐๐๐ซ๐ค๐๐ญ:ย https://www.imarcgroup.com/combine-harvesters-market
๐๐จ๐ฆ๐ฆ๐๐ซ๐๐ข๐๐ฅ ๐๐๐๐ซ๐ข๐ ๐๐ซ๐๐ญ๐ข๐จ๐ง ๐๐๐ซ๐ค๐๐ญ:ย https://www.imarcgroup.com/commercial-refrigeration-market
๐๐จ๐จ๐ ๐๐ฎ๐ฅ๐ฉ ๐๐๐ซ๐ค๐๐ญ:ย https://www.imarcgroup.com/wood-pulp-market
๐๐๐ญ๐๐ข๐ฅ ๐๐๐๐๐ฒ ๐๐๐๐ค๐๐ ๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ:ย https://www.imarcgroup.com/retail-ready-packaging-market
๐๐จ๐ญ๐: ๐๐ ๐ฒ๐จ๐ฎ ๐ซ๐๐ช๐ฎ๐ข๐ซ๐ ๐๐ง๐ฒ ๐ฌ๐ฉ๐๐๐ข๐๐ข๐ ๐ข๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง ๐ญ๐ก๐๐ญ ๐ข๐ฌ ๐ง๐จ๐ญ ๐๐จ๐ฏ๐๐ซ๐๐ ๐๐ฎ๐ซ๐ซ๐๐ง๐ญ๐ฅ๐ฒ ๐ฐ๐ข๐ญ๐ก๐ข๐ง ๐ญ๐ก๐ ๐ฌ๐๐จ๐ฉ๐ ๐จ๐ ๐ญ๐ก๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ, ๐ฐ๐ ๐ฐ๐ข๐ฅ๐ฅ ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐ ๐ญ๐ก๐ ๐ฌ๐๐ฆ๐ ๐๐ฌ ๐ ๐ฉ๐๐ซ๐ญ ๐จ๐ ๐ญ๐ก๐ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง.
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐ฌ:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immunoglobulin Market Set to Surge to USD 24.9 Billion by 2032 at a 5.1% CAGR here
News-ID: 3692639 • Views: โฆ
More Releases from IMARC Group

Flexible Printed Circuits Manufacturing Plant Cost 2025: Industry Trends, Unit S โฆ
Setting up a flexible printed circuits manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations.
IMARC Group's report titled "Flexible Printed Circuits Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing aโฆ

Needle Manufacturing Plant 2025: Project Report, Business Plan, Raw Materials, a โฆ
Setting up a needle manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations.
IMARC Group's report titled "Needle Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a needle manufacturing plant, coveringโฆ

Edible Oil Manufacturing Plant Setup Cost 2025: CapEx/OpEx Analysis with Profita โฆ
Setting up an edible oil manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations.
IMARC Group's report titled "Edible Oil Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing an edible oilโฆ

Copper Alloys Manufacturing Plant Setup Cost 2025: Layout, Machinery, Raw Materi โฆ
Setting up a copper alloys manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations.
IMARC Group's report titled "Copper Alloys Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a copper alloysโฆ
More Releases for Immunoglobulin
Key Subcutaneous Immunoglobulin (SCIG) Market Trend for 2025-2034: Advancements โฆ
What Is the Future Outlook for the Subcutaneous Immunoglobulin (SCIG) Market's Size and Growth Rate?
There has been a rapid expansion in the subcutaneous immunoglobulin (SCIG) market size in the previous years. It's projected to swell from $12.72 billion in 2024 to $14.52 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 14.1%. The upsurge in the past era is credited to the heightened occurrence of immunodeficiency disorders,โฆ
Intravenous Immunoglobulin Market CAGR of intravenous immunoglobulin market is t โฆ
The report is designed to provide a holistic view of the Intravenous Immunoglobulin Market .It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China, Southโฆ
Boosting Immunity: Innovations in Subcutaneous Immunoglobulin (SCIG)
The Business Research Company recently released a comprehensive report on the Global Subcutaneous Immunoglobulin (SCIG) Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Yourโฆ
Intravenous Immunoglobulin Market CAGR of intravenous immunoglobulin market is t โฆ
The report is designed to provide a holistic view of the Intravenous Immunoglobulin Market . It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; revenue, demands, and supply data (as applicable). Regional estimates and forecasts & trend analysis for eac country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Luxemburg, Rest of Europe, Japan, China,โฆ
Korea Intravenous Immunoglobulin Market Analysis to 2031
Intravenous Immunoglobulin Market Outlook 2031
Theย global intravenous immunoglobulin marketย was valued atย US$ 11.2 Bnย inย 2021
It is estimated to grow at a CAGR ofย 7.3%ย from 2022 to 2031
Theย global intravenous immunoglobulin marketย is expected to reach value ofย US$ 20.5 Bnย by the end ofย 2031
Get Sample Copy of the Report@
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1930
Overview of Intravenous Immunoglobulin Market
Immunoglobulins are highly purified, sterile-specific medical therapy solutions containing gamma globulin G (IgG) in a concentration of 95% or more. These are manufactured from a highlyโฆ
Immunoglobulin Market 2021 | Detailed Report
Global Immunoglobulin Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) ofโฆ